4//SEC Filing
Green Charles Bruce 4
Accession 0001818382-22-000165
CIK 0001818382other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:43 PM ET
Size
5.4 KB
Accession
0001818382-22-000165
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Green Charles Bruce
Director
Transactions
- Award
Stock Options (right to buy)
2022-09-15+13,000→ 13,000 totalExercise: $4.09Exp: 2032-09-15→ Common Stock (13,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on September 15, 2023, after which 1/48 of the option will become exercisable on the 15th of each month through September 15, 2026.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001945398
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:43 PM ET
- Size
- 5.4 KB